SEC Form 4 · accession 0001209191-18-045276
Dolby Laboratories, Inc. · DLB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin J Yeaman
Officer — President and CEO · Director
Period of report
Aug 1, 2018
Accepted (ET)
Aug 3, 2018 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001308547
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Aug 1, 2018 | S | 14,900 | $64.4719 | D | 32,995 | I | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
| Class A Common Stock | Aug 1, 2018 | S | 100 | $64.97 | D | 32,895 | I | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
| Class A Common StockF2 | holding | — | — | — | 114,828 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $63.965 to $64.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- F2Shares held following the reported transactions include 114,828 restricted stock units, which are subject to forfeiture until they vest.
Remarks
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.